Is Taxorest FDA approved?
No. This profile records Taxorest as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE LUNG HEALER
A-11 Lung Bioregulator
Taxorest is a lung-derived bioregulator peptide extracted from alveolar tissue. It promotes surfactant production, supports regeneration of lung epithelial cells, and reduces pulmonary inflammation. It's used for COPD, pulmonary fibrosis, recovery from respiratory infections, and general lung health with aging or environmental exposure.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Taxorest as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 20 mg daily (oral or subcutaneous).
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Upregulates surfactant proteins (SP-A, SP-B)
Stimulates type II pneumocyte proliferation
Suppresses NF-κB inflammatory mediators
Enhances lung antioxidant enzyme activity
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.